Skip to main content
欧康医药 logo

欧康医药 — Investor Relations & Filings

Ticker · 920230 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 373 across all filing types
Latest filing 2023-11-14 Governance Information
Country CN China
Listing Beijing Stock Exchange 920230

About 欧康医药

https://www.okaypharm.com/

Oukang Pharmaceutical specializes in the research, development, and large-scale production of natural plant extracts, with a primary focus on citrus-derived flavonoids. The company’s core product portfolio includes high-purity ingredients such as Hesperidin, Diosmin, Methyl Hesperidin, and Neohesperidin Dihydrochalcone (NHDC). These products serve as essential raw materials for the global pharmaceutical, nutraceutical, food and beverage, and cosmetic sectors. Utilizing advanced extraction and purification technologies, the company maintains rigorous quality control standards to ensure compliance with international regulatory requirements. Its operations emphasize the industrialization of plant-based chemical derivatives to support diverse health and wellness applications.

Recent filings

Filing Released Lang Actions
对外投资管理制度
Governance Information Classification · 95% confidence The document is a detailed announcement of the company's external investment management system, including governance, approval procedures, organizational management, personnel management, financial management, and transfer/recall of investments. It is issued by the company's board and includes voting results from a board meeting. The document is not a financial report, audit report, or earnings release. It is not a proxy statement or voting results announcement. It is a governance-related document detailing internal rules and procedures for external investments. Therefore, it fits best under Governance Information (CGR). The document length (6421 characters) and content confirm it is a full governance policy document, not a brief announcement or a report publication notice.
2023-11-14 Chinese
信息披露管理制度
Governance Information Classification · 95% confidence The document is a detailed disclosure management system of a company listed on the Beijing Stock Exchange (北交所). It extensively covers the company's information disclosure policies, responsibilities, types of reports (annual, interim, quarterly, and temporary reports), procedures for board and shareholder meetings, transaction disclosures, related party transactions, and other regulatory compliance matters. It references regulatory laws such as the Securities Law of China and the Beijing Stock Exchange listing rules. The document is a comprehensive internal governance and compliance manual related to information disclosure rather than an actual financial report or announcement. It does not contain financial statements, earnings data, or audit opinions. It is not a report publication announcement or a short notice but a substantive governance document outlining disclosure policies and procedures. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2023-11-14 Chinese
独立董事工作制度
Governance Information Classification · 95% confidence The document is a detailed corporate governance policy titled 'Independent Director Work System' issued by Chengdu Oukang Pharmaceutical Co., Ltd. It outlines the qualifications, nomination, duties, and operational procedures for independent directors, referencing relevant laws and regulatory guidelines. It is not a financial report, earnings release, or announcement of voting results. It is a governance-related document detailing internal rules and board structure. Therefore, it fits the category of Governance Information (CGR). The document length and content confirm it is the actual policy text, not just an announcement or summary.
2023-11-14 Chinese
内部审计制度
Regulatory Filings Classification · 90% confidence The document is titled "成都欧康医药股份有限公司内部审计制度" which translates to "Internal Audit System of Chengdu Oukang Pharmaceutical Co., Ltd." It details the company's internal audit policies, procedures, responsibilities, and reporting mechanisms. It includes references to internal control, audit committee reporting, and compliance with regulatory requirements. The document is a formal announcement of the company's internal audit system and related governance, not a standalone audit report or financial statement. It is not an annual report, earnings release, or management discussion. It is a regulatory announcement about internal audit policies and procedures, which fits best under Audit Report / Information (AR) as it relates to audit information and internal control systems, but since it is a policy document rather than an audit result or report, it is more aligned with Regulatory Filings (RNS) as a general regulatory announcement about internal audit system establishment. The document is about internal audit system establishment and governance, not a report of audit results or financial data. Therefore, the best classification is Regulatory Filings (RNS).
2023-11-14 Chinese
累积投票实施细则
Governance Information Classification · 95% confidence The document is a detailed set of rules titled '累积投票实施细则' (Cumulative Voting Implementation Rules) issued by the company's board. It discusses procedures for electing directors and supervisors, voting rights, nomination processes, and election principles. It references the company's articles of association and relevant laws. The document is not a report of financial results, audit, or earnings, nor is it a simple announcement or voting result. It is a governance-related document detailing internal rules and procedures for board elections. Therefore, it fits best under Governance Information (CGR). The document length is 3528 characters, which is substantial and contains detailed procedural content, not just an announcement or summary.
2023-11-14 Chinese
关于拟修订《公司章程》公告
Governance Information Classification · 95% confidence The document is a detailed announcement regarding proposed amendments to the company's Articles of Association (公司章程). It includes extensive legal and regulatory references, detailed clause-by-clause revisions, and governance-related content such as board composition, independent directors, shareholder rights, and meeting procedures. The document does not contain financial statements, audit opinions, or earnings data. It is not a report of voting results or a notice of a meeting but a formal announcement of proposed governance changes. This fits the category of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2023-11-14 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.